# A Study of Cabergoline for the Treatment of Cocaine Dependence - 1

> **NCT00033111** · PHASE2 · COMPLETED · sponsor: **National Institute on Drug Abuse (NIDA)** · enrollment: 140 (actual)

## Conditions studied

- Cocaine-Related Disorders
- Substance-Related Disorders

## Interventions

- **DRUG:** Cabergoline
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00033111
- **Lead sponsor:** National Institute on Drug Abuse (NIDA)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-06
- **Primary completion:** —
- **Final completion:** 2004-04
- **Target enrollment:** 140 (ACTUAL)
- **Last updated:** 2017-01-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00033111

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00033111, "A Study of Cabergoline for the Treatment of Cocaine Dependence - 1". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00033111. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*